Vivoryon (VVY) | Stock Overview & Key Data
Vivoryon Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: €27.19 on January 11, 2016
Explore how other NL stocks compare to their 52-week ranges: View NL Market 52-Week Insights
Key Statistics
Financial Highlights
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Vivoryon
VVY
|
37.02M Small-cap | -8.06% | -8.80% | -16.79% | -24.50% | -21.38% | -29.88% | -91.69% | -93.20% | -93.99% | -94.14% | -94.14% |
|
Galapagos NV
GLPGA
|
1.63B Large-cap | 1.96% | 6.58% | -12.43% | -6.24% | -11.43% | -1.66% | -35.89% | -60.48% | -44.69% | 414.23% | 177.11% |
|
Pharming Group N.V
PHARM
|
1.02B Large-cap | 0.00% | 0.00% | -21.28% | -21.28% | -21.28% | -21.83% | -21.83% | -21.83% | -21.83% | -21.83% | -21.83% |
|
Koninklijke Philips
PHIA
|
22.16B Large-cap | 2.76% | 5.68% | -1.37% | -1.37% | -1.37% | -2.85% | -2.85% | -2.85% | -2.85% | -2.85% | -2.85% |
|
Renewi Plc
RWI
|
830.45M Small-cap | 0.39% | 1.58% | 3.83% | 3.83% | 3.83% | 31.71% | 23.95% | 244.48% | 2,295.35% | 2,295.35% | 2,295.35% |
| 137.51M Small-cap | 0.00% | 33.33% | -6.54% | -7.41% | -7.41% | -8.26% | -7.41% | -7.41% | -7.41% | -7.41% | -7.41% |
Ownership & Short Interest
Calculate Your Vivoryon Investment Returns
Long-Term Investment Performance Analysis
Vivoryon stock price in Jul 2016 was €19.27, A €1,000.00 lump sum investment in Vivoryon made 9 years ago would be worth approximately €59.16 today, representing a negative return of -94.08%. This translates to an annualized return (CAGR) of -24.83%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is VVY's 52-week high and low?
- In the last 52 weeks, Vivoryon reached a high of €1.84 (on N/A) and a low of €1.10 (on June 15, 2026).
- What is the market cap and P/E ratio for VVY?
- Curious about Vivoryon's size and valuation? Its market capitalization stands at 37.02M. When it comes to valuation, the P/E ratio (trailing twelve months) is -1.58, and the forward P/E (looking ahead) is -3.27.
- Does VVY pay dividends? If so, what's the yield?
- As for dividends, Vivoryon isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Vivoryon's main competitors or similar companies to consider before investing?
When looking at Vivoryon, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Galapagos NV
GLPGA1.63B Healthcare Biotechnology -1.66% -35.89% Pharming Group N.V
PHARM1.02B Healthcare Biotechnology -21.83% -21.83% Koninklijke Philips
PHIA22.16B Healthcare Medical Devices -2.85% -2.85% Renewi Plc
RWI830.45M Industrials Waste Management 31.71% 23.95% London Tunnels PLC
TLT137.51M Industrials Engineering & Construction -8.26% -7.41% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Vivoryon Therapeutics N.V.? (e.g., ROE, Debt/Equity)
- To get a sense of Vivoryon's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -145.47%, the Debt to Equity ratio from the most recent quarter is 2.26, and its Gross Profit Margin stands at N/A.
- What is the recent revenue and earnings growth for VVY?
- Looking at Vivoryon's growth, its revenue over the trailing twelve months (TTM) was €0. Compared to the same quarter last year (YoY), quarterly revenue grew by N/A, and quarterly earnings saw a YoY growth of N/A.
- How much of VVY stock is held by insiders and institutions?
- Wondering who owns Vivoryon stock? Company insiders (like executives and directors) hold about 21.46% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 8.90%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.